Clinical Oncology Next Generation Sequencing Market Size is Predicted to Witness 15.7% CAGR till 2030

 

The global Clinical Oncology Next Generation Sequencing Market size is expected to reach USD 1.16 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.7% from 2023 to 2030. The clinical oncology next generation sequencing (NGS) market is in high demand. It is projected to expand at an increasing rate throughout the forecast period owing to the rising healthcare expenditure triggering the development of effective personalized medicine & therapeutic procedures for cancer and increasing adoption of NGS.

The increasing healthcare expenses and the launch of effective cancer treatments are expected to fuel market growth over the forecast period. A study published by the JAMA network in February 2023 estimated that the cost of cancer treatment can reach up to USD 25 trillion globally over the 30 years from 2020-2030. The comparative contribution of treatment expenses to the total economic expense of cancers was found to be more significant in high-income nations than in low-income nations. Moreover, various treatment techniques are being developed and utilized to diagnose and treat cancer. According to the study published by Wiley in January 2023, technological advances that are being used to develop new diagnostic techniques include image reconstruction software, imaging devices, hardware, biomarkers, and artificial intelligence algorithms, thereby delivering a reliable analysis and diagnosis of the tumor.

Furthermore, the growth of the clinical oncology next-generation sequencing market during the forecast period is propelled by the rise in the adoption of NGS over single gene testing. Many studies demonstrated that NGS is cost-effective and efficient over single gene testing. For instance, a study published by JCO Precision Oncology in March 2023 concluded that the adoption of NGS in Spanish reference centers to diagnose patients with NSCLC could be a cost-effective strategy over single gene testing. In addition, the study given by the National Library of Medicine in January 2023, suggests that the current NGS over sequential single-gene testing can slightly reduce annual costs. However, embracing NSG over SSG testing can decrease the average turnaround time, facilitating quicker identification of genomic alterations and early initiating therapy for small cell lung cancer patients in Japan. These factors are expected to drive the market over the forecast period.

List of Key Players of Clinical Oncology Next Generation Sequencing (NGS) Market

• Illumina, Inc.
• Thermo Fisher Scientific
• F. Hoffmann-La Roche Ltd.
• Agilent Technologies, Inc.
• Myriad Genetics
• Beijing Genomics Institute (BGI)
• PerkinElmer,Inc.
• Foundation Medicine
• PacBio
• Oxford Nanopore Technologies
• Paradigm Diagnostics
• Caris Life Sciences
• Partek Incorporated
• Eurofins Scientific
• QIAGEN

Related Press Release@ Clinical Oncology Next Generation Sequencing Market Report

Clinical Oncology Next Generation Sequencing Market Report Highlights

• In the workflow segment, NGS sequencing dominated the market with a revenue share of 56.0% in 2022, owing to technological advancements and the rising number of cancer sequencing projects
• By technology, the targeted sequencing and resequencing accounted for the largest revenue share of 72.7% in the clinical oncology NGS market in 2022. This can be attributed to the growing clinical utility of targeted panels and their efficiency in detecting cancer tumors
• By application, the screening segment held the highest share of 80.1% in 2022. The segment's dominance is due to the increasing prevalence of cancer worldwide
• By end-use, the laboratories segment accounted for the largest share of 64.1% in the clinical oncology NGS market in 2022. This can be attributed to the rising number of research and development activities
• North America held the largest market share of 48.68% in 2022. The dominance of the region is due to the presence of prominent international players in the market and rising investments from public and private organizations in life science research & solutions developments in the region

Clinical Oncology Next Generation Sequencing Market Report Scope

Report Attribute	Details
Market size value in 2023	USD 419.6 million
Revenue forecast in 2030	USD 1.16 billion
Growth rate	CAGR of 15.7% from 2023 to 2030
Base year for estimation	2022
Historical data	2018 - 2021
Forecast period	2023 - 2030

 

Clinical Oncology Next Generation Sequencing Market Segmentation

Grand View Research has segmented the global clinical oncology next generation sequencing market based on technology, workflow, application, end use, and region:

Clinical Oncology Next Generation Sequencing (NGS) Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Whole Genome Sequencing
• Whole Exome Sequencing
• Targeted Sequencing & Resequencing

Clinical Oncology Next Generation Sequencing (NGS) Workflow Outlook (Revenue, USD Million, 2018 - 2030)

• NGS Pre-Sequencing
• NGS Sequencing
• NGS Data Analysis

Clinical Oncology Next Generation Sequencing (NGS) Application Outlook (Revenue, USD Million, 2018 - 2030)

• Screening
• Sporadic Cancer
• Inherited Cancer
• Companion Diagnostics
• Other Diagnostics

Clinical Oncology Next Generation Sequencing (NGS) End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Clinics
• Laboratories

Clinical Oncology Next Generation Sequencing (NGS) Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• South Korea
• Australia
• Thailand
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• UAE
• Kuwait

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

 

Pet Dental Health Market Size To Reach $9.98 Billion By 2030

 

The global Pet Dental Health Market size is expected to reach USD 9.98 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.25% from 2023 to 2030.Increasing pet companion ownership, rising demand for pet dental care products, and rising prevalence of pet dental diseases are the major drivers of the market.Dental diseases are common in companion animals, such as dogs and cats, affecting almost 78% to 80% of dogs and around 70% of cats over 3 years of age. According to VCA Animal Hospitals, periodontal diseases, also referred to as gum diseases, are the most common dental conditions reported in dogs. The increased prevalence of a variety of oral health-related disorders has been highlighted as a significant driver of market growth.

The American Pet Product Association (APPA) estimates that 86.9 million households in the U.S. own a pet, with 65.1 million households owning dogs as per the 2023-2024 National Pet Owners Survey. Every year, pet owners spend an average of USD 49.70 on dental care for their dogs. Furthermore, pet owners' growing awareness about animal oral health and an increase in the number of dental treatments are driving the growth of the market.  The most common dental condition, such as periodontitis, according to the American Veterinary Medical Association (AVMA), can cause serious health problems ranging from tooth loss to organ damage. The COVID-19 outbreak is having a mixed effect on the pet dental care product industry. Due to the shutdown of vet clinics and specialized salons, the need for pet oral care products has increased.

During the lockdown, several online businesses also experienced big sales. Chewy.com got around 70% of its revenue from subscribers and has seen an increase in revenues since February 2020. As a result of the pandemic, the penetration of e-commerce pet oral care products and medicines has increased.The market is fairly concentrated, with major worldwide companies holding a considerable market share. Many strategic efforts have been undertaken by the leading industryplayers to expand their market share. They are concentrating on new product releases, mergers and acquisitions, and expansions to reach a larger consumer base. For instance, in May 2023, Virbac, a global animal health company, acquired a distributor in the Czech Republic and Slovakia.

This acquisition will allow Virbac to expand its presence and strengthen its position in the Central European market. In June 2021, Nestlé Purina PetCare invested USD 182 million in King William County to expand its manufacturing business to meet the growing consumer demand. North America dominated the market and accounted for a revenue share of over 38% in 2022 owing to the growing need to mitigate unexpected veterinary costs and the penetration of pet insurance. On the other hand, Asia Pacific is likely to exhibit the fastest CAGR over the forecast period due to the rising disposable income, increasing pet adoption, and presence of several local market players.

Related Press Release@ Pet Dental Health Market Report

Pet Dental Health Market Report Highlights

• By animal type segment, dogs accounted for the largest market share revenue of over 58% in 2022, owing to the increasing rate of dog ownership as a companion animal in several households.
• Service typewas the largest revenue-generating segment in 2022. This is owing to the presence of several service providers, the rapid uptake of pet dental services, and the rising medicalization rate
• Within the Indication segment, gum disease accounted for the largest market share in 2022. Periodontitis, the most common oral gum illness in dogs over the age of three, is connected with intrinsic variables, such as prevalent in small breed dogs and progression with age
• By distribution channel, veterinary hospitals & clinics dominated the market with a share of over 40% in 2022owing to the large patient volume appointed for dental cleaning procedures
• The global market is competitive as major players are focusing on investments, partnerships, collaborations, mergers & acquisitions, and expansion strategies to improve their industry penetration
• In January 2022, Swedencare AB completed the acquisition of the Italian company Innovet, one of Italy's top and most lucrative veterinary supplement companies. Swedencare will have a strong foothold in the Italian pet healthcare sector as a result of the acquisition

Pet Dental Health Market Segmentation

Grand View Research has segmented the global pet dental health market on the basis of type, animal type, indication, distribution channel, and region:

Pet Dental Health Type Outlook (Revenue, USD Million, 2018 - 2030)

• Products
• Oral Care Products

• Tooth Pastes & Brushes
• Oral Care Solutions
• Foods & Treats
• Dental Chews
• Dental Powder
• Others
• Medicines
• Equipment
• Services
• Diagnosis
• Treatment
• Dental Cleaning
• Surgery
• Root Canal Therapy
• Others

Pet Dental Health Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

• Dogs
• Cats
• Others

Pet Dental Health Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Gum Disease
• Endodontic Diseases
• Dental Calculus
• Oral Tumor
• Others

Pet Dental Health Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Veterinary Hospitals & Clinics
• Retail Pharmacies
• E-commerce
• Others

Pet Dental Health Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East & Africa
• South Africa
• Saudi Arabia
• Rest of MEA

List of Key Players in Pet Dental Health Market

• Virbac
• Colgate- Palmolive Company
• Dechra Pharmaceuticals plc
• Nestlé Purina Pet Care
• Vetoquinol SA
• Nylabone (Central Garden & Pet Company)
• Barkbox
• imRex Inc.
• Basepaws, Inc.
• Animal Microbiome Analytics, Inc.
• Dentalaire, International
• Pedigree (Mars Incorporate)
• PetIQ, LLC.
• Animal Dental Clinic
• Petzlife UK 

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Dermatoscope Market Size is Predicted to Witness 12.1% CAGR till 2030

 

The global Dermatoscope Market size is expected to reach USD 2.0 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 12.1% during the forecast period. Dermatoscopy plays a vital role in screening for skin cancer, which has resulted in the early detection and identification of pigmented lesions. Benign pigmented moles possess a certain risk of developing melanoma.

The incidence of several skin conditions has increased during the COVID-19 pandemic. Contact dermatitis, pressure urticaria, pressure injury, itching, seborrheic dermatitis, acne, and worsening of pre-existing skin diseases. The Dermatology Practical & Conceptual conducted a survey on 678 dermatologists to investigate the impact of the coronavirus disease 2019 outbreak on the daily practice of dermatologists working with skin cancer patients. This survey stated that there was a 75% reduction in daily work activity and 118 dermatologists experienced telemedicine for the first time. However, with the ease in the restrictions, the aesthetic industry is again witnessing lucrative growth rate.

Skin cancer is a chronic disease affecting a large population of the world. The rising incidence of melanoma and nonmelanoma skin cancers is providing an upthrust to the market. Certain moles, such as giant congenital pigmented hairy moles, are at high risk of developing melanoma. This has boosted the need for effective diagnosis with dermatoscopes.

Early detection of skin cancer has been proven to be very useful in its effective treatment. Hence, a rising number of awareness campaigns is estimated to fuel the demand for dermatoscopes, which is anticipated to propel the market. Earlier, the usage of these technologically advanced devices was limited to the detection of noninvasive melanoma. However, with technological advancements, their application has widened to the advanced diagnosis of various skin disorders.

North America region is currently the dominant region in terms of market share in dermatoscopes market. High prevalence of skin diseases, the presence of advanced healthcare infrastructure, presence of medical device manufacturers, and huge economic development are some of the major factors propels the North America dermatoscopes market.

Related Press Release@ Dermatoscope Market Report

Dermatoscope Market Report Highlights

• Contact dermatoscopes dominated the market in 2022 owing to abundant availability of these products
• Hybrid dermatoscopes are anticipated to exhibit lucrative CAGR over the forecast period owing to unique features of contact as well as noncontact dermatoscopes
• In 2022, LED technology held the largest market share owing to benefits associated with its usage, which include exact light intensity, color, and, homogeneity rendering precise diagnosis
• Handheld devices generated maximum revenue share in 2022 due to the fact that they are relatively compact and consist of rechargeable batteries that enable easy manoeuvring across the body
• Amongst end use segments, dermatology clinics dominated the market in 2022 and is also expected to exhibit attractive growth over the forecast period
• The availability of sophisticated and technologically advanced medical equipment at dermatology clinics provides patients quick and rapid diagnosis, which helps deliver better treatment
• North America held largest market share in 2022 owing to increase in the prevalence of skin cancer and growth in the adoption of advanced diagnostic technologies in this region
• Asia Pacific is anticipated to exhibit attractive growth over the forecast period due to the introduction of novel technologies in countries such as Japan and China

Dermatascope Market Segmentation

Grand View Research has segmented the global dermatascope market based on product, technology, modality, end-use, and region:

Dermatoscope Product Outlook (Revenue, USD Million, 2018 - 2030)

• Contact Dermatoscope
• Hybrid Dermatoscope
• Noncontact Dermatoscope

Dermatoscope Technology Outlook (Revenue, USD Million, 2018 - 2030)

• LED
• Xenon
• Halogen
• Ultraviolet

Dermatoscope Modality Outlook (Revenue, USD Million, 2018 - 2030)

• Handheld
• Trolley Mounted
• Headband

Dermatoscope End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Dermatology Clinics
• Hospitals

Dermatoscope Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Mexico
• Argentina
• MEA
• South Africa
• Saudi Arabia
• UAE
• Kuwait

List of Key Players of Dermatoscope Market

• Canfield Scientific, Inc.
• 3Gen
• FotoFinder Systems
• Optilia Instruments AB
• HEINE Optotechnik GmbH & Co. KG
• Caliber Imaging & Diagnostics, Inc.
• Firefly Global
• ILLUCO Corporation Ltd.
• Welch Allyn
• Bio-Therapeutic Inc.

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com